Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction

Bellis, L.; Moitinho, E.; Abraldes, J.G.; Graupera, M.; García-Pagán, J.C.; Rodés, J.; Bosch, J.
January 2003
Gut;Jan2003, Vol. 52 Issue 1, p130
Academic Journal
Background and aims: Up to 60% of patients treated with transjugular intrahepatic portosystemic shunt (TIPS) require angioplasty or restenting during the first year of follow up because of TIPS dysfunction (stenosis of the intrahepatic shunt increasing the portal pressure gradient above the 12 mm Hg threshold). We hypothesised that in patients with TIPS stenosis, propranolol administration, by decreasing portal inflow, would markedly decrease portal pressure. Patients and methods: Eighteen patients with TIPS dysfunction were investigated by measuring portal pressure gradient before and after acute propranolol administration (0.2 mg/kg intravenously; n=18). Results: Propranolol markedly reduced the portal pressure gradient (from 16.6 (3.5) to 11.9 (4.8) mm Hg; p<0.0001), cardiac index (-26 (7)%), and heart rate (-18 (7)%) (p<0.0001). Portal pressure gradient decreased to less than 12 mm Hg in nine patients, more frequently in those with moderate dysfunction (portal pressure gradient 16 mm Hg) than in patients with severe dysfunction (portal pressure gradient >16 mm Hg) (8/10 v 1/8; p=0.015). Conclusions: Propranolol therapy may delay the increase in portal pressure and reduce the need for reintervention in patients with TIPS dysfunction.


Related Articles

  • Management Challenges of Liver Cirrhosis. Sadovsky, Richard // American Family Physician;2/15/2000, Vol. 61 Issue 4, p1127 

    Provides information on the study `Cirrhosis of Liver,' by B.S. Anand published in the August 1999 issue of the `Western Journal of Medicine.'

  • Mercaptopurine.  // Reactions Weekly;Aug2014, Vol. 1512 Issue 1, p27 

    The article presents a case study of a 12-year-old boy who was admitted to hospital for non-cirrhotic portal hypertension after being treated for Cohn's disease (CD).

  • DECOMPENSATED CIRRHOSIS; PREVALENCE OF GASTRIC VARICES. Iqbal, Sarwat; Yousaf, Muhammad Haroon; Yousuf, Muhammad Ifitikhar; Wasim-Uddin // Professional Medical Journal;2015, Vol. 22 Issue 11, p1397 

    Cirrhosis with subsequent portal hypertension is a major health problem worldwide. Among various etiologies, HCV is the leading cause of chronic hepatocellular injury. Cirrhosis being the commonest cause of portal hypertension results in a spectrum of complications. Approximately 5-15% of...

  • Idiopathic Presinusoidal Portal Hypertension (Banti's Syndrome). Polish, Edwin; Christie, John; Cohen, Arthur; Sullivan Jr., Benjamin // Annals of Internal Medicine;Apr62, Vol. 56 Issue 4, p624 

    Presents the case of a 23-year-old Caucasian male that bears resemblance to the early stages of Banti's syndrome, characterized by splenomegaly and cirrhosis of the liver. Stages of the disease; Indications that the portal hypertension was presinusoidal in origin; Absence of neurological...

  • Understanding portal hypertension.  // American Family Physician;4/1/1997, Vol. 55 Issue 5, p1861 

    Discusses information about portal hypertension. Meaning of portal hypertension; How it is caused by a condition called cirrhosis; Causes of cirrhosis; Treatments for cirrhosis and portal hypertension.

  • Effect of cimetidine on portal hypertension in cirrhotic patients. Burroughs, A.K.; Walt, R.; Dunk, A.; Jenkins, W.; Sherlock, S.; Mackie, S.; Dick, R. // British Medical Journal (Clinical Research Edition);4/17/1982, Vol. 284 Issue 6323, p1159 

    Examines the effects of cimetidine on portal hypertension in cirrhotic patients. Reduction of hepatic blood flow in normal subjects; Use of cimetidine as alternative to propranolol; Measurement of wedged and free hepatic venous pressures.

  • Obliterative Portal Venopathy of the Liver and ‘Idiopathic Portal Hypertension’. Iber, Frank L. // Annals of Internal Medicine;Sep69, Vol. 71 Issue 3, p660 

    Deals with the role of obliterative portal venopathy of the liver in idiopathic portal hypertension. Comments on the study by Reynolds et al in the 1969 issue of 'Annals of Internal Medicine' on portal hypertension without cirrhosis in alcoholic liver disease; Presence of portal hypertension in...

  • Evaluation of Rectal Mucosal Hemodynamics in Patients with Liver Cirrhosis Using Reflectance Spectrophotometry. Tezuha, Takashi; Akita, Yasushi; Yoshikawa, Nozomi; Mitamura, Keiji // American Journal of Gastroenterology;Jun1997, Vol. 92 Issue 6, p1022 

    Objectives: Portal hypertensive colonopathy is observed in patients with liver cirrhosis. To determine the correlation between rectal mucosal hemodynamics and portal hypertensive colonopathy, we observed rectal mucosal findings and measured rectal mucosal hemodynamics in patients with liver...

  • Clonidine for Portal Hypertension: A Sympathetic Solution? Blendis, Laurence M. // Annals of Internal Medicine;3/15/92, Vol. 116 Issue 6, p515 

    Studies the efficacy of clonidine, a centrally active alpha-2 adrenergic agonist for treating portal hypertension in patients with alcoholic cirrhosis. Decrease in the cardiac output and heart rate of the patients with clonidine; Effect of clonidine on mean arterial pressure of the patients;...

  • Comparison of prevalence for paraumbilical vein patency in patients with viral and alcoholic liver cirrhosis. Chen, Chien-Hung; Wang, Jing-Houng; Lu, Sheng-Nan; Tung, Wei-Chih; Hung, Chao-Hung; Lee, Chuan-Mo; Changchien, Chi-Sin // American Journal of Gastroenterology;Sep2002, Vol. 97 Issue 9, p2415 

    OBJECTIVES:The patent paraumbilical vein (PUV) is a venous collateral that is often found in patients with cirrhosis and portal hypertension. It can be effectively demonstrated by conventional ultrasonography (US). We conducted this prospective study to elucidate the prevalence and etiology of...


Read the Article


Sign out of this library

Other Topics